COSCIENS Biopharma Inc.
CSCIF
$2.08
-$0.08-3.92%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.91M | -18.84M | -17.56M | -15.31M | -1.15M |
| Total Depreciation and Amortization | 1.29M | 1.48M | 1.57M | 1.61M | 2.53M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.01M | 4.72M | 2.17M | 1.67M | -2.02M |
| Change in Net Operating Assets | 607.00K | -4.47M | -226.00K | -2.51M | -1.76M |
| Cash from Operations | -10.00M | -17.11M | -14.05M | -14.55M | -2.39M |
| Capital Expenditure | -973.00K | -1.10M | -1.21M | -1.16M | -1.56M |
| Sale of Property, Plant, and Equipment | 9.00K | 5.00K | 4.00K | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 26.04M | 26.04M | 26.04M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.00K | 203.00K | 203.00K | 207.00K | 207.00K |
| Cash from Investing | -975.00K | -896.00K | 25.03M | 25.08M | 24.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -459.00K | -488.00K | -549.00K | -443.00K | -591.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -135.00K | -209.00K | -167.00K | -167.00K | -74.00K |
| Cash from Financing | -594.00K | -697.00K | -716.00K | -610.00K | -652.00K |
| Foreign Exchange rate Adjustments | 97.00K | 227.00K | -17.00K | -211.00K | 23.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.47M | -18.47M | 10.25M | 9.72M | 21.66M |